| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.8 | 0.004 | 0.8 | Aldehyde oxidase inhibitor | 0.536 0.028 DBMET01559 0.578 0.022 DBMET03063 0.578 0.022 DBMET03064 | ||
| 0.569 | 0.001 | 0.569 | Histamine N-methyltransferase inhibitor | 0.416 0.002 DBMET01559 0.519 0.002 DBMET03063 0.344 0.003 DBMET03064 | ||
| 0.505 | 0.058 | 0.505 | Caspase 9 stimulant | 0.324 0.169 DBMET01559 0.407 0.107 DBMET03063 0.453 0.082 DBMET03064 | ||
| 0.401 | 0.002 | 0.549 | Botulinum neurotoxin type A inhibitor | 0.44 0.002 DBMET01559 0.549 0.002 DBMET03063 0.238 0.003 DBMET03064 | DBMET03063 | |
| 0.337 | 0.028 | 0.361 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.261 0.055 DBMET01559 0.361 0.022 DBMET03063 0.248 0.061 DBMET03064 | DBMET03063 | |
| 0.318 | 0.013 | 0.318 | Nav1.2 sodium channel blocker | 0.191 0.038 DBMET01559 0.261 0.02 DBMET03063 0.106 0.102 DBMET03064 | ||
| 0.318 | 0.042 | 0.318 | Amyloid beta aggregation inhibitor | 0.25 0.058 DBMET01559 0.23 0.064 DBMET03063 | ||
| 0.336 | 0.06 | 0.659 | 5 Hydroxytryptamine release stimulant | 0.659 0.01 DBMET01559 0.532 0.023 DBMET03063 0.424 0.041 DBMET03064 | DBMET01559 | |
| 0.314 | 0.048 | 0.314 | Antiamyloidogenic | 0.269 0.063 DBMET01559 0.25 0.071 DBMET03063 0.229 0.081 DBMET03064 | ||
| 0.358 | 0.096 | 0.432 | Histamine release inhibitor | 0.213 0.187 DBMET01559 0.382 0.085 DBMET03063 0.432 0.059 DBMET03064 | DBMET03064 | |
| 0.315 | 0.054 | 0.315 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.27 0.088 DBMET01559 0.311 0.056 DBMET03063 0.255 0.102 DBMET03064 | ||
| 0.319 | 0.063 | 0.319 | Spasmolytic | 0.197 0.123 DBMET01559 | ||
| 0.293 | 0.04 | 0.293 | Sigma receptor agonist | |||
| 0.258 | 0.012 | 0.258 | ATPase inhibitor | 0.204 0.034 DBMET01559 0.175 0.065 DBMET03063 0.188 0.048 DBMET03064 | ||
| 0.244 | 0.01 | 0.244 | Nav1.6 sodium channel blocker | 0.171 0.034 DBMET01559 0.192 0.022 DBMET03063 0.153 0.051 DBMET03064 | ||
| 0.348 | 0.117 | 0.406 | 5 Hydroxytryptamine release inhibitor | 0.248 0.23 DBMET01559 0.327 0.137 DBMET03063 0.406 0.075 DBMET03064 | DBMET03064 | |
| 0.275 | 0.05 | 0.335 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.181 0.087 DBMET01559 0.335 0.032 DBMET03063 0.181 0.087 DBMET03064 | DBMET03063 | |
| 0.325 | 0.1 | 0.653 | GABA C receptor rho-3 antagonist | 0.338 0.092 DBMET01559 0.379 0.071 DBMET03063 0.653 0.004 DBMET03064 | DBMET03064 | |
| 0.274 | 0.05 | 0.303 | Psychostimulant | 0.303 0.042 DBMET01559 0.277 0.049 DBMET03063 0.2 0.08 DBMET03064 | DBMET01559 | |
| 0.277 | 0.058 | 0.332 | 5 Hydroxytryptamine uptake stimulant | 0.332 0.031 DBMET01559 0.325 0.034 DBMET03063 0.283 0.054 DBMET03064 | DBMET01559 | |
| 0.28 | 0.065 | 0.28 | Cardiotonic | 0.169 0.153 DBMET01559 | ||
| 0.269 | 0.058 | 0.269 | Potassium channel blocker | 0.158 0.128 DBMET01559 0.207 0.088 DBMET03064 | ||
| 0.265 | 0.066 | 0.319 | Superoxide dismutase inhibitor | 0.253 0.073 DBMET01559 0.319 0.044 DBMET03063 0.239 0.082 DBMET03064 | DBMET03063 | |
| 0.218 | 0.019 | 0.218 | Nav1.3 sodium channel blocker | 0.206 0.022 DBMET01559 0.124 0.07 DBMET03063 | ||
| 0.251 | 0.055 | 0.251 | Neuropeptide Y2 antagonist | 0.213 0.098 DBMET01559 0.234 0.072 DBMET03063 | ||
| 0.201 | 0.01 | 0.201 | NADH dehydrogenase inhibitor | 0.107 0.037 DBMET01559 0.118 0.03 DBMET03063 0.162 0.015 DBMET03064 | ||
| 0.225 | 0.039 | 0.268 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.139 0.072 DBMET01559 0.268 0.026 DBMET03063 0.173 0.054 DBMET03064 | DBMET03063 | |
| 0.207 | 0.022 | 0.207 | Alpha 2b adrenoreceptor antagonist | 0.187 0.027 DBMET01559 0.121 0.057 DBMET03063 0.146 0.04 DBMET03064 | ||
| 0.204 | 0.021 | 0.204 | Butyrylcholinesterase inhibitor | 0.148 0.035 DBMET01559 0.086 0.075 DBMET03063 0.175 0.026 DBMET03064 | ||
| 0.225 | 0.063 | 0.229 | DNA methylase inhibitor | 0.155 0.113 DBMET01559 0.15 0.117 DBMET03063 0.229 0.061 DBMET03064 | DBMET03064 | |
| 0.208 | 0.06 | 0.226 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.122 0.114 DBMET01559 0.226 0.053 DBMET03063 0.156 0.085 DBMET03064 | DBMET03063 | |
| 0.176 | 0.033 | 0.176 | DNA intercalator | 0.133 0.051 DBMET01559 0.127 0.054 DBMET03063 0.104 0.07 DBMET03064 | ||
| 0.165 | 0.031 | 0.165 | Chelator | 0.139 0.04 DBMET01559 0.108 0.067 DBMET03063 | ||
| 0.152 | 0.02 | 0.236 | Telomerase inhibitor | 0.103 0.032 DBMET01559 0.092 0.038 DBMET03063 0.236 0.01 DBMET03064 | DBMET03064 | |
| 0.187 | 0.055 | 0.278 | Protein kinase (CK1) gamma 3 inhibitor | 0.145 0.096 DBMET01559 0.236 0.031 DBMET03063 0.278 0.021 DBMET03064 | DBMET03064 | |
| 0.137 | 0.006 | 0.137 | Potassium channel (ATP-sensitive) blocker | 0.099 0.016 DBMET01559 0.081 0.027 DBMET03063 0.122 0.008 DBMET03064 | ||
| 0.182 | 0.051 | 0.218 | Death-associated protein kinase 2 inhibitor | 0.149 0.109 DBMET01559 0.218 0.024 DBMET03063 0.186 0.047 DBMET03064 | DBMET03063 | |
| 0.173 | 0.043 | 0.197 | Acetylcholinesterase inhibitor | 0.121 0.077 DBMET01559 0.197 0.034 DBMET03064 | DBMET03064 | |
| 0.257 | 0.127 | 0.257 | Vasodilator, coronary | 0.238 0.147 DBMET01559 | ||
| 0.145 | 0.033 | 0.145 | Falcipain inhibitor | 0.136 0.037 DBMET01559 0.137 0.037 DBMET03063 0.08 0.073 DBMET03064 | ||
| 0.115 | 0.005 | 0.143 | Corticotropin releasing factor 2 receptor antagonist | 0.107 0.005 DBMET01559 0.143 0.004 DBMET03063 0.087 0.012 DBMET03064 | DBMET03063 | |
| 0.113 | 0.004 | 0.113 | CC chemokine 4 receptor antagonist | 0.078 0.008 DBMET01559 0.062 0.014 DBMET03063 0.052 0.024 DBMET03064 | ||
| 0.185 | 0.077 | 0.206 | DNA methyltransferase I inhibitor | 0.206 0.066 DBMET03064 | DBMET03064 | |
| 0.14 | 0.033 | 0.14 | Falcipain 2 inhibitor | 0.129 0.038 DBMET01559 0.132 0.037 DBMET03063 0.079 0.071 DBMET03064 | ||
| 0.193 | 0.088 | 0.212 | Anticonvulsant | 0.145 0.136 DBMET01559 0.18 0.099 DBMET03063 0.212 0.074 DBMET03064 | DBMET03064 | |
| 0.166 | 0.065 | 0.187 | Cholinergic | 0.187 0.053 DBMET03064 | DBMET03064 | |
| 0.15 | 0.051 | 0.37 | Glutamate receptor antagonist | 0.175 0.035 DBMET01559 0.211 0.023 DBMET03063 0.37 0.006 DBMET03064 | DBMET03064 | |
| 0.162 | 0.064 | 0.162 | Acetylcholine M1 receptor antagonist | 0.133 0.092 DBMET01559 0.135 0.09 DBMET03063 0.119 0.11 DBMET03064 | ||
| 0.133 | 0.04 | 0.133 | Nav1.1 sodium channel blocker | |||
| 0.124 | 0.033 | 0.185 | Electrolyte absorption antagonist | 0.088 0.079 DBMET03063 0.185 0.01 DBMET03064 | DBMET03064 | |
| 0.196 | 0.105 | 0.266 | Peptidyltransferase inhibitor | 0.251 0.05 DBMET01559 0.266 0.04 DBMET03063 | DBMET03063 | |
| 0.243 | 0.155 | 0.393 | Calcium channel activator | 0.393 0.027 DBMET03064 | DBMET03064 | |
| 0.098 | 0.01 | 0.31 | Potassium channel (Ca-activated) blocker | 0.076 0.021 DBMET01559 0.079 0.019 DBMET03063 0.31 0.004 DBMET03064 | DBMET03064 | |
| 0.178 | 0.097 | 0.34 | Interleukin antagonist | 0.177 0.099 DBMET01559 0.34 0.04 DBMET03063 | DBMET03063 | |
| 0.148 | 0.068 | 0.19 | Neuropeptide Y1 antagonist | 0.19 0.023 DBMET01559 0.173 0.036 DBMET03063 0.133 0.095 DBMET03064 | DBMET01559 | |
| 0.084 | 0.009 | 0.193 | Potassium channel small-conductance Ca-activated blocker | 0.056 0.02 DBMET01559 0.071 0.012 DBMET03063 0.193 0.004 DBMET03064 | DBMET03064 | |
| 0.182 | 0.112 | 0.301 | ErbB-1 antagonist | 0.301 0.033 DBMET03064 | DBMET03064 | |
| 0.189 | 0.125 | 0.25 | DNA damaging | 0.186 0.128 DBMET01559 0.226 0.096 DBMET03063 0.25 0.08 DBMET03064 | DBMET03064 | |
| 0.166 | 0.105 | 0.302 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.139 0.131 DBMET01559 0.242 0.049 DBMET03063 0.302 0.027 DBMET03064 | DBMET03064 | |
| 0.115 | 0.054 | 0.115 | Alpha 2c adrenoreceptor antagonist | 0.103 0.063 DBMET01559 0.113 0.055 DBMET03064 | ||
| 0.152 | 0.091 | 0.152 | Cyclin-dependent kinase 3 inhibitor | 0.145 0.108 DBMET01559 0.15 0.096 DBMET03064 | ||
| 0.068 | 0.008 | 0.068 | Benzodiazepine antagonist | 0.049 0.028 DBMET01559 0.054 0.02 DBMET03064 | ||
| 0.119 | 0.063 | 0.218 | Interleukin 8 antagonist | 0.107 0.082 DBMET01559 0.15 0.034 DBMET03063 0.218 0.009 DBMET03064 | DBMET03064 | |
| 0.065 | 0.01 | 0.065 | Plasmepsin II inhibitor | 0.049 0.019 DBMET01559 0.056 0.014 DBMET03063 | ||
| 0.136 | 0.085 | 0.166 | Thiol protease inhibitor | 0.131 0.095 DBMET01559 0.166 0.057 DBMET03063 0.132 0.093 DBMET03064 | DBMET03063 | |
| 0.112 | 0.062 | 0.257 | Acetylcholine release stimulant | 0.257 0.004 DBMET03064 | DBMET03064 | |
| 0.107 | 0.056 | 0.122 | Factor V inhibitor | 0.119 0.039 DBMET01559 0.122 0.037 DBMET03063 | DBMET03063 | |
| 0.098 | 0.048 | 0.173 | NMDA receptor antagonist | 0.127 0.032 DBMET01559 0.173 0.019 DBMET03063 0.171 0.019 DBMET03064 | DBMET03063 | |
| 0.07 | 0.02 | 0.07 | Bcl-xL inhibitor | 0.061 0.037 DBMET01559 0.06 0.039 DBMET03063 | ||
| 0.158 | 0.111 | 0.242 | Death-associated protein kinase 3 inhibitor | 0.147 0.127 DBMET01559 0.204 0.073 DBMET03063 0.242 0.055 DBMET03064 | DBMET03064 | |
| 0.168 | 0.122 | 0.168 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.112 | 0.067 | 0.131 | CDK3/cyclin E inhibitor | 0.131 0.042 DBMET01559 0.121 0.055 DBMET03063 0.108 0.073 DBMET03064 | DBMET01559 | |
| 0.149 | 0.105 | 0.218 | Neurotensin receptor agonist | 0.191 0.04 DBMET01559 0.218 0.028 DBMET03063 0.171 0.061 DBMET03064 | DBMET03063 | |
| 0.179 | 0.136 | 0.243 | Calpain inhibitor | 0.243 0.071 DBMET01559 0.17 0.148 DBMET03063 | DBMET01559 | |
| 0.061 | 0.023 | 0.061 | Potassium channel (Inward rectifier) blocker | 0.06 0.024 DBMET03064 | ||
| 0.134 | 0.097 | 0.178 | MAP kinase 3 inhibitor | 0.129 0.11 DBMET03063 0.178 0.036 DBMET03064 | DBMET03064 | |
| 0.07 | 0.033 | 0.129 | NMDA 2C receptor antagonist | 0.056 0.051 DBMET01559 0.118 0.011 DBMET03063 0.129 0.009 DBMET03064 | DBMET03064 | |
| 0.059 | 0.022 | 0.07 | Potassium channel (Inward rectifier) activator | 0.07 0.012 DBMET01559 0.057 0.024 DBMET03063 0.061 0.018 DBMET03064 | DBMET01559 | |
| 0.05 | 0.013 | 0.05 | Cathepsin F inhibitor | 0.047 0.016 DBMET01559 0.046 0.018 DBMET03063 | ||
| 0.097 | 0.061 | 0.178 | Lanosterol 14 alpha demethylase inhibitor | 0.114 0.037 DBMET03063 0.178 0.005 DBMET03064 | DBMET03064 | |
| 0.067 | 0.031 | 0.082 | Heat shock protein 90 beta antagonist | 0.075 0.024 DBMET01559 0.056 0.047 DBMET03063 0.082 0.019 DBMET03064 | DBMET03064 | |
| 0.056 | 0.02 | 0.067 | Potassium channel (ATP-sensitive) activator | 0.067 0.011 DBMET01559 0.054 0.023 DBMET03063 0.058 0.017 DBMET03064 | DBMET01559 | |
| 0.126 | 0.092 | 0.128 | Aurora-C kinase inhibitor | 0.12 0.106 DBMET01559 0.128 0.088 DBMET03064 | DBMET03064 | |
| 0.212 | 0.177 | 0.293 | Calpain 2 inhibitor | 0.293 0.119 DBMET01559 | DBMET01559 | |
| 0.197 | 0.162 | 0.226 | Insulysin inhibitor | 0.189 0.175 DBMET01559 0.226 0.121 DBMET03063 | DBMET03063 | |
| 0.201 | 0.168 | 0.201 | Caspase 3 stimulant | |||
| 0.093 | 0.061 | 0.239 | Protein kinase C zeta inhibitor | 0.106 0.043 DBMET01559 0.157 0.018 DBMET03063 0.239 0.008 DBMET03064 | DBMET03064 | |
| 0.095 | 0.064 | 0.105 | Interleukin 1 beta converting enzyme inhibitor | 0.105 0.052 DBMET01559 0.091 0.071 DBMET03063 | DBMET01559 | |
| 0.042 | 0.012 | 0.042 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.182 | 0.152 | 0.245 | 5 Hydroxytryptamine 1E antagonist | 0.245 0.08 DBMET03064 | DBMET03064 | |
| 0.085 | 0.057 | 0.096 | Myeloperoxidase inhibitor | 0.092 0.046 DBMET01559 0.096 0.04 DBMET03063 0.095 0.041 DBMET03064 | DBMET03063 | |
| 0.138 | 0.111 | 0.333 | LIM domain kinase 1 inhibitor | 0.131 0.119 DBMET01559 0.198 0.064 DBMET03063 0.333 0.014 DBMET03064 | DBMET03064 | |
| 0.064 | 0.039 | 0.096 | 5 Hydroxytryptamine 5A antagonist | 0.096 0.017 DBMET03064 | DBMET03064 | |
| 0.104 | 0.079 | 0.104 | Interleukin 2 antagonist | |||
| 0.044 | 0.02 | 0.044 | Growth hormone secretagogue receptor antagonist | |||
| 0.052 | 0.03 | 0.104 | Topoisomerase II beta inhibitor | 0.104 0.009 DBMET03064 | DBMET03064 | |
| 0.046 | 0.026 | 0.066 | Histamine H1 receptor agonist | 0.066 0.005 DBMET01559 0.057 0.01 DBMET03063 0.055 0.012 DBMET03064 | DBMET01559 | |
| 0.077 | 0.058 | 0.077 | Acetylcholine nicotinic antagonist | |||
| 0.086 | 0.068 | 0.184 | Potassium channel (Ca-activated) activator | 0.088 0.067 DBMET03063 0.184 0.018 DBMET03064 | DBMET03064 | |
| 0.058 | 0.04 | 0.094 | 5 Hydroxytryptamine 5 antagonist | 0.094 0.016 DBMET03064 | DBMET03064 | |
| 0.119 | 0.101 | 0.454 | Peroxidase inhibitor | 0.117 0.103 DBMET03063 0.454 0.014 DBMET03064 | DBMET03064 | |
| 0.04 | 0.022 | 0.048 | Potassium channel Kv1.1 blocker | 0.048 0.014 DBMET01559 0.044 0.018 DBMET03063 0.037 0.029 DBMET03064 | DBMET01559 | |
| 0.114 | 0.096 | 0.133 | Cytokine production inhibitor | 0.118 0.091 DBMET01559 0.133 0.076 DBMET03063 | DBMET03063 | |
| 0.058 | 0.041 | 0.12 | Glutamate (mGluR1) antagonist | 0.116 0.012 DBMET01559 0.12 0.011 DBMET03063 0.113 0.013 DBMET03064 | DBMET03063 | |
| 0.03 | 0.014 | 0.03 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.103 | 0.087 | 0.103 | Acetylcholine muscarinic antagonist | |||
| 0.093 | 0.079 | 0.12 | Folate antagonist | 0.108 0.052 DBMET01559 0.12 0.039 DBMET03063 | DBMET03063 | |
| 0.033 | 0.02 | 0.033 | GHS receptor antagonist | |||
| 0.128 | 0.115 | 0.274 | Heat shock protein 90 alpha antagonist | 0.18 0.062 DBMET01559 0.159 0.078 DBMET03063 0.274 0.019 DBMET03064 | DBMET03064 | |
| 0.075 | 0.062 | 0.075 | Viral attachment inhibitor | |||
| 0.068 | 0.057 | 0.085 | Phospholipase D inhibitor | 0.085 0.027 DBMET03064 | DBMET03064 | |
| 0.097 | 0.085 | 0.097 | Anesthetic local | |||
| 0.104 | 0.092 | 0.143 | MAP kinase 12 inhibitor | 0.12 0.07 DBMET03063 0.143 0.047 DBMET03064 | DBMET03064 | |
| 0.102 | 0.093 | 0.102 | Cholinergic antagonist | |||
| 0.036 | 0.027 | 0.036 | Factor XIIIa inhibitor | |||
| 0.124 | 0.116 | 0.154 | Pregnane X receptor agonist | 0.154 0.046 DBMET03064 | DBMET03064 | |
| 0.068 | 0.06 | 0.068 | Acetylcholine M4 receptor antagonist | |||
| 0.018 | 0.012 | 0.019 | Potassium channel (Inward rectifier) 11 blocker | 0.019 0.012 DBMET01559 0.017 0.015 DBMET03063 0.018 0.014 DBMET03064 | DBMET01559 | |
| 0.022 | 0.016 | 0.022 | Corticotropin releasing factor 1 receptor antagonist | |||
| 0.099 | 0.093 | 0.099 | Acetylcholine antagonist | |||
| 0.04 | 0.035 | 0.066 | NMDA receptor subunit 3B antagonist | 0.042 0.032 DBMET03063 0.066 0.017 DBMET03064 | DBMET03064 | |
| 0.08 | 0.075 | 0.096 | Potassium channel activator | 0.092 0.057 DBMET01559 0.096 0.053 DBMET03064 | DBMET03064 | |
| 0.059 | 0.056 | 0.059 | Bcl2 antagonist | |||
| 0.051 | 0.05 | 0.109 | CXC chemokine 4 receptor antagonist | 0.059 0.043 DBMET01559 0.109 0.023 DBMET03063 | DBMET03063 | |
| 0.097 | 0.097 | 0.101 | Cell adhesion inhibitor | 0.101 0.087 DBMET01559 0.097 0.095 DBMET03063 | DBMET01559 | |
| 0.03 | 0.032 | 0.041 | Phosphoglycerate kinase inhibitor | 0.041 0.019 DBMET03063 0.037 0.022 DBMET03064 | DBMET03063 | |
| 0.107 | 0.109 | 0.154 | Toll-Like receptor antagonist | 0.12 0.084 DBMET03063 0.154 0.053 DBMET03064 | DBMET03064 | |
| 0.109 | 0.112 | 0.204 | Activin receptor-like kinase 2 inhibitor | 0.204 0.035 DBMET03064 | DBMET03064 | |
| 0.018 | 0.021 | 0.024 | Toll-Like receptor 8 agonist | 0.024 0.007 DBMET03063 | DBMET03063 | |
| 0.15 | 0.154 | 0.214 | Immunostimulant | 0.214 0.112 DBMET03063 | DBMET03063 | |
| 0.106 | 0.11 | 0.187 | Histone deacetylase SIRT1 inhibitor | 0.169 0.047 DBMET01559 0.187 0.036 DBMET03063 | DBMET03063 | |
| 0.059 | 0.064 | 0.175 | NMDA 2 receptor antagonist | 0.081 0.043 DBMET01559 0.132 0.021 DBMET03063 0.175 0.012 DBMET03064 | DBMET03064 | |
| 0.14 | 0.147 | 0.178 | Focal adhesion kinase 2 inhibitor | 0.178 0.09 DBMET03064 | DBMET03064 | |
| 0.06 | 0.067 | 0.076 | CXC chemokine receptor antagonist | 0.076 0.041 DBMET03063 | DBMET03063 | |
| 0.029 | 0.036 | 0.049 | NMDA receptor subunit 3A antagonist | 0.049 0.02 DBMET03064 | DBMET03064 | |
| 0.1 | 0.107 | 0.126 | Cathepsin H inhibitor | 0.114 0.083 DBMET01559 0.126 0.068 DBMET03063 0.121 0.073 DBMET03064 | DBMET03063 | |
| 0.104 | 0.111 | 0.222 | Protein kinase (CK1) gamma inhibitor | 0.147 0.069 DBMET03063 0.222 0.037 DBMET03064 | DBMET03064 | |
| 0.021 | 0.029 | 0.039 | AMPA 3 receptor antagonist | 0.035 0.017 DBMET01559 0.039 0.014 DBMET03063 0.034 0.017 DBMET03064 | DBMET03063 | |
| 0.076 | 0.086 | 0.104 | Platelet activating factor alpha antagonist | 0.104 0.056 DBMET03064 | DBMET03064 | |
| 0.118 | 0.13 | 0.279 | GABA C receptor rho-2 antagonist | 0.154 0.069 DBMET01559 0.279 0.007 DBMET03064 | DBMET03064 | |
| 0.087 | 0.1 | 0.102 | Topoisomerase II inhibitor | 0.102 0.084 DBMET01559 | DBMET01559 | |
| 0.066 | 0.08 | 0.109 | Adrenaline agonist | 0.109 0.031 DBMET01559 | DBMET01559 | |
| 0.16 | 0.174 | 0.199 | 5 Hydroxytryptamine 3E antagonist | 0.192 0.076 DBMET01559 0.182 0.1 DBMET03063 0.199 0.065 DBMET03064 | DBMET03064 | |
| 0.058 | 0.077 | 0.076 | Alpha 2a adrenoreceptor antagonist | 0.076 0.052 DBMET03064 | DBMET03064 | |
| 0.115 | 0.134 | 0.357 | CDC-like kinase 4 inhibitor | 0.146 0.104 DBMET03063 0.357 0.02 DBMET03064 | DBMET03064 | |
| 0.049 | 0.069 | 0.085 | NMDA receptor agonist | 0.066 0.039 DBMET01559 0.085 0.026 DBMET03063 0.078 0.03 DBMET03064 | DBMET03063 | |
| 0.111 | 0.132 | 0.202 | Heat shock protein 90 antagonist | 0.138 0.087 DBMET01559 0.202 0.037 DBMET03064 | DBMET03064 | |
| 0.031 | 0.052 | 0.04 | AMPA 4 receptor antagonist | 0.036 0.034 DBMET03063 0.04 0.026 DBMET03064 | DBMET03064 | |
| 0.084 | 0.107 | 0.152 | c-Src kinase inhibitor | 0.152 0.054 DBMET03064 | DBMET03064 | |
| 0.073 | 0.097 | 0.147 | Transforming growth factor beta 3 antagonist | 0.091 0.036 DBMET03063 0.147 0.005 DBMET03064 | DBMET03064 | |
| 0.083 | 0.107 | 0.095 | 5 Hydroxytryptamine 2B antagonist | 0.095 0.09 DBMET03064 | DBMET03064 | |
| 0.066 | 0.092 | 0.076 | Insulin growth factor antagonist | 0.076 0.074 DBMET03064 | DBMET03064 | |
| 0.041 | 0.067 | 0.049 | Sodium/calcium exchanger inhibitor | 0.049 0.036 DBMET03064 | DBMET03064 | |
| 0.1 | 0.126 | 0.197 | Protein kinase (CK1) gamma 1 inhibitor | 0.135 0.082 DBMET03063 0.197 0.043 DBMET03064 | DBMET03064 | |
| 0.055 | 0.081 | 0.133 | Transforming growth factor antagonist | 0.133 0.009 DBMET03064 | DBMET03064 | |
| 0.023 | 0.05 | 0.052 | Complement C3a chemotactic receptor antagonist | 0.042 0.031 DBMET01559 0.052 0.025 DBMET03063 | DBMET03063 | |
| 0.022 | 0.049 | 0.041 | Methionyl aminopeptidase 1 inhibitor | 0.041 0.011 DBMET03064 | DBMET03064 | |
| 0.068 | 0.095 | 0.077 | Histamine H2 receptor antagonist | 0.077 0.071 DBMET01559 | DBMET01559 | |
| 0.076 | 0.105 | 0.123 | Nitric-oxide synthase inhibitor | 0.1 0.06 DBMET01559 0.116 0.04 DBMET03063 0.123 0.036 DBMET03064 | DBMET03064 | |
| 0.064 | 0.096 | 0.073 | Neuropeptide Y antagonist | 0.073 0.071 DBMET01559 | DBMET01559 | |
| 0.039 | 0.071 | 0.063 | Myc inhibitor | 0.063 0.026 DBMET01559 | DBMET01559 | |
| 0.029 | 0.062 | 0.067 | NMDA 2A receptor antagonist | 0.052 0.036 DBMET01559 0.067 0.026 DBMET03063 | DBMET03063 | |
| 0.036 | 0.069 | 0.064 | Toll-Like receptor 8 antagonist | 0.054 0.037 DBMET03063 0.064 0.028 DBMET03064 | DBMET03064 | |
| 0.081 | 0.115 | 0.153 | Histone deacetylase class III inhibitor | 0.134 0.058 DBMET01559 0.153 0.041 DBMET03063 | DBMET03063 | |
| 0.053 | 0.087 | 0.06 | Beta 2 adrenoreceptor agonist | 0.06 0.05 DBMET01559 | DBMET01559 | |
| 0.11 | 0.144 | 0.166 | Polo-like kinase-3 inhibitor | 0.129 0.111 DBMET03063 0.166 0.069 DBMET03064 | DBMET03064 | |
| 0.028 | 0.064 | 0.039 | Neurokinin 2 agonist | 0.039 0.033 DBMET03063 | DBMET03063 | |
| 0.021 | 0.057 | 0.043 | MAP3K8 inhibitor | 0.043 0.005 DBMET03064 | DBMET03064 | |
| 0.074 | 0.111 | 0.172 | Protein kinase (CK2) alpha inhibitor | 0.097 0.079 DBMET03063 0.172 0.032 DBMET03064 | DBMET03064 | |
| 0.097 | 0.135 | 0.187 | Src kinase inhibitor | 0.187 0.061 DBMET03064 | DBMET03064 | |
| 0.06 | 0.098 | 0.079 | Alpha 2 adrenoreceptor antagonist | 0.079 0.067 DBMET03064 | DBMET03064 | |
| 0.063 | 0.102 | 0.083 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.083 0.066 DBMET03063 | DBMET03063 | |
| 0.117 | 0.156 | 0.269 | Interleukin 6 antagonist | 0.269 0.02 DBMET03064 | DBMET03064 | |
| 0.071 | 0.11 | 0.083 | Hematopoietic | 0.083 0.064 DBMET03063 | DBMET03063 | |
| 0.05 | 0.09 | 0.063 | Potassium channel large-conductance Ca-activated activator | 0.063 0.054 DBMET03064 | DBMET03064 | |
| 0.029 | 0.069 | 0.162 | AMPA receptor antagonist | 0.046 0.035 DBMET03063 0.162 0.005 DBMET03064 | DBMET03064 | |
| 0.009 | 0.05 | 0.017 | Histamine H4 receptor agonist | 0.017 0.014 DBMET03063 | DBMET03063 | |
| 0.055 | 0.097 | 0.086 | Platelet growth factor antagonist | 0.086 0.051 DBMET03064 | DBMET03064 | |
| 0.009 | 0.053 | 0.026 | AMPA 1 receptor antagonist | 0.026 0.023 DBMET03063 0.025 0.024 DBMET03064 | DBMET03063 | |
| 0.074 | 0.118 | 0.132 | Glutamate release inhibitor | 0.084 0.077 DBMET01559 0.088 0.066 DBMET03063 0.132 0.015 DBMET03064 | DBMET03064 | |
| 0.049 | 0.094 | 0.129 | Glutamate (mGluR group I) antagonist | 0.129 0.018 DBMET03064 | DBMET03064 | |
| 0.021 | 0.066 | 0.034 | Melanocortin 1 antagonist | 0.034 0.03 DBMET03063 | DBMET03063 | |
| 0.015 | 0.061 | 0.035 | Endothelial nitric-oxide synthase inhibitor | 0.031 0.022 DBMET01559 0.035 0.017 DBMET03063 0.03 0.022 DBMET03064 | DBMET03063 | |
| 0.03 | 0.077 | 0.065 | Dihydrofolate reductase inhibitor | 0.045 0.026 DBMET03063 0.065 0.008 DBMET03064 | DBMET03064 | |
| 0.043 | 0.091 | 0.109 | Phenylalanine 4-hydroxylase inhibitor | 0.109 0.022 DBMET03064 | DBMET03064 | |
| 0.035 | 0.084 | 0.075 | Glucagon-like peptide 1 agonist | 0.075 0.038 DBMET03063 | DBMET03063 | |
| 0.06 | 0.11 | 0.139 | Aminopeptidase B inhibitor | 0.139 0.043 DBMET03063 | DBMET03063 | |
| 0.056 | 0.106 | 0.118 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.081 0.034 DBMET01559 0.074 0.049 DBMET03063 0.118 0.006 DBMET03064 | DBMET03064 | |
| 0.011 | 0.063 | 0.018 | Alpha 2b adrenoreceptor agonist | 0.018 0.015 DBMET03064 | DBMET03064 | |
| 0.087 | 0.138 | 0.309 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.182 0.058 DBMET03063 0.309 0.024 DBMET03064 | DBMET03064 | |
| 0.049 | 0.102 | 0.099 | Nicotinic alpha4beta2 receptor antagonist | 0.073 0.058 DBMET03063 0.099 0.032 DBMET03064 | DBMET03064 | |
| 0.058 | 0.112 | 0.072 | Vanilloid 4 agonist | 0.072 0.059 DBMET01559 | DBMET01559 | |
| 0.007 | 0.061 | 0.014 | Somatostatin 2 agonist | 0.014 0.011 DBMET03063 | DBMET03063 | |
| 0.038 | 0.094 | 0.066 | Epithelial sodium channel blocker | 0.066 0.021 DBMET03064 | DBMET03064 | |
| 0.091 | 0.148 | 0.207 | Interleukin 1 antagonist | 0.207 0.03 DBMET03064 | DBMET03064 | |
| 0.007 | 0.064 | 0.025 | Cyclin T1 inhibitor | 0.025 0.007 DBMET03064 | DBMET03064 | |
| 0.026 | 0.085 | 0.06 | Neuropeptide agonist | 0.06 0.038 DBMET03063 | DBMET03063 | |
| 0.084 | 0.145 | 0.174 | Toll-Like receptor 9 antagonist | 0.174 0.048 DBMET03064 | DBMET03064 | |
| 0.036 | 0.1 | 0.077 | Alpha 2 adrenoreceptor agonist | 0.077 0.026 DBMET03064 | DBMET03064 | |
| 0.016 | 0.081 | 0.029 | Purinergic P2Y15 antagonist | 0.029 0.019 DBMET03064 | DBMET03064 | |
| 0.039 | 0.104 | 0.108 | Alpha adrenoreceptor agonist | 0.108 0.025 DBMET03064 | DBMET03064 | |
| 0.06 | 0.125 | 0.163 | Pim-3 kinase inhibitor | 0.163 0.015 DBMET03064 | DBMET03064 | |
| 0.033 | 0.099 | 0.045 | Bombesin 2 receptor antagonist | 0.045 0.042 DBMET01559 | DBMET01559 | |
| 0.086 | 0.151 | 0.153 | Protein kinase C nu inhibitor | 0.126 0.087 DBMET03063 0.153 0.068 DBMET03064 | DBMET03064 | |
| 0.064 | 0.129 | 0.109 | Interleukin 5 antagonist | 0.109 0.032 DBMET03064 | DBMET03064 | |
| 0.017 | 0.083 | 0.03 | Complement factor 1r inhibitor | 0.03 0.011 DBMET03064 | DBMET03064 | |
| 0.098 | 0.164 | 0.219 | Cyclin-dependent kinase 8 inhibitor | 0.124 0.112 DBMET03063 0.219 0.025 DBMET03064 | DBMET03064 | |
| 0.033 | 0.099 | 0.049 | Parathyroid hormone antagonist | 0.049 0.024 DBMET03063 | DBMET03063 | |
| 0.068 | 0.135 | 0.133 | T cell inhibitor | 0.133 0.012 DBMET03064 | DBMET03064 | |
| 0.023 | 0.09 | 0.038 | Protein kinase (CK2) beta inhibitor | 0.038 0.015 DBMET03064 | DBMET03064 | |
| 0.071 | 0.139 | 0.146 | Protein kinase (CK1) gamma 2 inhibitor | 0.103 0.081 DBMET03063 0.146 0.051 DBMET03064 | DBMET03064 | |
| 0.101 | 0.169 | 0.365 | Clk dual-specificity kinase inhibitor | 0.136 0.127 DBMET03063 0.365 0.025 DBMET03064 | DBMET03064 | |
| 0.017 | 0.085 | 0.028 | 5 Hydroxytryptamine 6 agonist | 0.028 0.021 DBMET03064 | DBMET03064 | |
| 0.091 | 0.16 | 0.16 | Diuretic | 0.126 0.098 DBMET03063 0.16 0.069 DBMET03064 | DBMET03064 | |
| 0.036 | 0.105 | 0.066 | Alpha 1b adrenoreceptor agonist | 0.066 0.014 DBMET03064 | DBMET03064 | |
| 0.042 | 0.111 | 0.122 | Benzodiazepine agonist | 0.122 0.015 DBMET03064 | DBMET03064 | |
| 0.015 | 0.084 | 0.038 | Somatostatin agonist | 0.038 0.018 DBMET03063 | DBMET03063 | |
| 0.031 | 0.101 | 0.059 | Histamine H4 receptor antagonist | 0.059 0.019 DBMET03064 | DBMET03064 | |
| 0.043 | 0.112 | 0.086 | Histone deacetylase SIRT2 inhibitor | 0.086 0.04 DBMET03063 | DBMET03063 | |
| 0.039 | 0.108 | 0.069 | Vanilloid antagonist | 0.069 0.057 DBMET03064 | DBMET03064 | |
| 0.071 | 0.141 | 0.124 | Nav1.4 sodium channel blocker | 0.124 0.048 DBMET03063 | DBMET03063 | |
| 0.019 | 0.092 | 0.048 | Somatostatin 5 agonist | 0.048 0.013 DBMET03063 | DBMET03063 | |
| 0.028 | 0.102 | 0.098 | Transforming growth factor beta 1 antagonist | 0.098 0.011 DBMET03064 | DBMET03064 | |
| 0.104 | 0.18 | 0.249 | MAP kinase kinase 2 inhibitor | 0.249 0.054 DBMET03064 | DBMET03064 | |
| 0.052 | 0.128 | 0.163 | Protein kinase (CK2) inhibitor | 0.163 0.028 DBMET03064 | DBMET03064 | |
| 0.057 | 0.132 | 0.103 | Alcohol dehydrogenase inhibitor | 0.103 0.049 DBMET03064 | DBMET03064 | |
| 0.047 | 0.122 | 0.063 | Histone deacetylase SIRT3 inhibitor | 0.058 0.054 DBMET01559 0.063 0.04 DBMET03063 | DBMET03063 | |
| 0.039 | 0.115 | 0.096 | Porphobilinogen synthase inhibitor | 0.096 0.038 DBMET03064 | DBMET03064 | |
| 0.126 | 0.204 | 0.173 | Cyclic AMP phosphodiesterase inhibitor | 0.173 0.119 DBMET03064 | DBMET03064 | |
| 0.014 | 0.093 | 0.057 | Kainate receptor antagonist | 0.057 0.018 DBMET03064 | DBMET03064 | |
| 0.088 | 0.166 | 0.169 | Anticoagulant | 0.169 0.066 DBMET03063 | DBMET03063 | |
| 0.03 | 0.109 | 0.052 | 5 Hydroxytryptamine 6 antagonist | 0.052 0.046 DBMET03064 | DBMET03064 | |
| 0.028 | 0.109 | 0.048 | H+/K+-transporting ATPase inhibitor | 0.048 0.04 DBMET03064 | DBMET03064 | |
| 0.028 | 0.11 | 0.052 | Histamine agonist | 0.052 0.037 DBMET01559 0.052 0.037 DBMET03063 | DBMET03063 | |
| 0.04 | 0.122 | 0.074 | Sirtuin 1 inhibitor | 0.065 0.051 DBMET01559 0.074 0.041 DBMET03063 | DBMET03063 | |
| 0.024 | 0.107 | 0.041 | 5 Hydroxytryptamine 2B agonist | 0.041 0.023 DBMET03064 | DBMET03064 | |
| 0.012 | 0.095 | 0.031 | Gonadotropin-releasing hormone receptor antagonist | 0.031 0.027 DBMET01559 | DBMET01559 | |
| 0.055 | 0.139 | 0.129 | MAP kinase 9 inhibitor | 0.129 0.045 DBMET03064 | DBMET03064 | |
| 0.007 | 0.091 | 0.021 | Alpha 2c adrenoreceptor agonist | 0.021 0.01 DBMET03064 | DBMET03064 | |
| 0.008 | 0.092 | 0.031 | Somatostatin 2 antagonist | 0.031 0.02 DBMET03063 | DBMET03063 | |
| 0.025 | 0.11 | 0.091 | Protein kinase C epsilon inhibitor | 0.056 0.034 DBMET03063 0.091 0.015 DBMET03064 | DBMET03064 | |
| 0.074 | 0.159 | 0.108 | CDC-like kinase 3 inhibitor | 0.108 0.062 DBMET03064 | DBMET03064 | |
| 0.063 | 0.149 | 0.192 | GABA C receptor rho-1 antagonist | 0.097 0.067 DBMET01559 0.132 0.031 DBMET03063 0.192 0.009 DBMET03064 | DBMET03064 | |
| 0.066 | 0.153 | 0.189 | GABA C receptor antagonist | 0.138 0.037 DBMET03063 0.189 0.015 DBMET03064 | DBMET03064 | |
| 0.109 | 0.197 | 0.133 | CC chemokine 6 receptor antagonist | 0.133 0.061 DBMET03064 | DBMET03064 | |
| 0.034 | 0.125 | 0.066 | MAP kinase kinase 9 inhibitor | 0.066 0.024 DBMET03064 | DBMET03064 | |
| 0.067 | 0.159 | 0.171 | Vascular endothelial growth factor 3 antagonist | 0.171 0.054 DBMET03064 | DBMET03064 | |
| 0.015 | 0.107 | 0.039 | DNA gyrase subunit B inhibitor | 0.039 0.025 DBMET03064 | DBMET03064 | |
| 0.061 | 0.153 | 0.111 | Granulocyte macrophage colony stimulating factor agonist | 0.111 0.022 DBMET03064 | DBMET03064 | |
| 0.014 | 0.11 | 0.07 | Proto-oncogene tyrosine-protein kinase Met inhibitor | 0.07 0.021 DBMET03064 | DBMET03064 | |
| 0.071 | 0.168 | 0.159 | Growth factor antagonist | 0.159 0.064 DBMET03064 | DBMET03064 | |
| 0.059 | 0.155 | 0.152 | Bromodomain-containing protein 2 inhibitor | 0.152 0.008 DBMET03064 | DBMET03064 | |
| 0.073 | 0.17 | 0.191 | Thrombolytic | 0.128 0.101 DBMET01559 0.191 0.056 DBMET03063 | DBMET03063 | |
| 0.008 | 0.106 | 0.029 | CC chemokine 9 receptor antagonist | 0.029 0.004 DBMET03064 | DBMET03064 | |
| 0.062 | 0.16 | 0.15 | MAP kinase kinase 1 inhibitor | 0.15 0.016 DBMET03064 | DBMET03064 | |
| 0.041 | 0.139 | 0.075 | MAP kinase kinase 10 inhibitor | 0.075 0.033 DBMET03064 | DBMET03064 | |
| 0.137 | 0.235 | 0.194 | Transcription factor STAT3 inhibitor | 0.194 0.142 DBMET03063 | DBMET03063 | |
| 0.037 | 0.137 | 0.079 | Rho-associated kinase I inhibitor | 0.079 0.047 DBMET03064 | DBMET03064 | |
| 0.019 | 0.119 | 0.065 | Glutamate (mGluR4) agonist | 0.065 0.007 DBMET03064 | DBMET03064 | |
| 0.093 | 0.194 | 0.179 | Anesthetic general | 0.179 0.087 DBMET03064 | DBMET03064 | |
| 0.078 | 0.178 | 0.166 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.132 0.092 DBMET03063 0.166 0.062 DBMET03064 | DBMET03064 | |
| 0.056 | 0.157 | 0.086 | Insulin receptor antagonist | 0.086 0.084 DBMET03064 | DBMET03064 | |
| 0.144 | 0.245 | 0.225 | Immunomodulator | 0.225 0.137 DBMET03063 | DBMET03063 | |
| 0.018 | 0.12 | 0.043 | Growth hormone release inhibitor | 0.043 0.028 DBMET03063 | DBMET03063 | |
| 0.055 | 0.158 | 0.117 | Aurora-B kinase inhibitor | 0.117 0.067 DBMET03064 | DBMET03064 | |
| 0.065 | 0.168 | 0.213 | Ribosomal protein S6 kinase inhibitor | 0.213 0.032 DBMET03064 | DBMET03064 | |
| 0.162 | 0.266 | 0.379 | Interleukin 2 agonist | 0.197 0.194 DBMET01559 0.316 0.063 DBMET03063 0.379 0.034 DBMET03064 | DBMET03064 | |
| 0.028 | 0.132 | 0.101 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.101 0.014 DBMET03064 | DBMET03064 | |
| 0.072 | 0.178 | 0.326 | CDC-like kinase 2 inhibitor | 0.326 0.025 DBMET03064 | DBMET03064 | |
| 0.042 | 0.149 | 0.112 | Somatostatin 1 agonist | 0.112 0.027 DBMET03063 | DBMET03063 | |
| 0.041 | 0.148 | 0.142 | Protein kinase B gamma inhibitor | 0.142 0.018 DBMET03063 0.074 0.053 DBMET03064 | DBMET03063 | |
| 0.034 | 0.142 | 0.102 | Rho-associated kinase inhibitor | 0.102 0.034 DBMET03064 | DBMET03064 | |
| 0.059 | 0.167 | 0.127 | MAP kinase 13 inhibitor | 0.127 0.05 DBMET03064 | DBMET03064 | |
| 0.025 | 0.133 | 0.065 | Cyclin A1 inhibitor | 0.065 0.03 DBMET03063 | DBMET03063 | |
| 0.019 | 0.129 | 0.059 | Bromodomain-containing protein 3 inhibitor | 0.059 0.022 DBMET03064 | DBMET03064 | |
| 0.043 | 0.153 | 0.139 | Ca(v)2.2 blocker | 0.139 0.032 DBMET03064 | DBMET03064 | |
| 0.05 | 0.162 | 0.123 | Cyclin-dependent kinase 5 inhibitor | 0.123 0.056 DBMET03064 | DBMET03064 | |
| 0.057 | 0.169 | 0.121 | EphA2 antagonist | 0.121 0.053 DBMET03064 | DBMET03064 | |
| 0.014 | 0.127 | 0.046 | Somatostatin 1 antagonist | 0.046 0.022 DBMET03063 | DBMET03063 | |
| 0.123 | 0.236 | 0.16 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.16 0.127 DBMET03064 | DBMET03064 | |
| 0.125 | 0.238 | 0.197 | MAP-kinase-activated kinase 5 inhibitor | 0.197 0.107 DBMET03064 | DBMET03064 | |
| 0.016 | 0.13 | 0.03 | Dipeptidyl peptidase II inhibitor | 0.03 0.027 DBMET03063 | DBMET03063 | |
| 0.049 | 0.163 | 0.088 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.088 0.052 DBMET03063 0.075 0.073 DBMET03064 | DBMET03063 | |
| 0.038 | 0.153 | 0.138 | Glutamate (mGluR) antagonist | 0.138 0.02 DBMET03064 | DBMET03064 | |
| 0.066 | 0.183 | 0.143 | Tyrosine kinase inhibitor | 0.143 0.093 DBMET03064 | DBMET03064 | |
| 0.022 | 0.139 | 0.054 | 5 Hydroxytryptamine 4 antagonist | 0.054 0.031 DBMET03064 | DBMET03064 | |
| 0.132 | 0.251 | 0.232 | RNA-directed DNA polymerase inhibitor | 0.232 0.063 DBMET03064 | DBMET03064 | |
| 0.036 | 0.156 | 0.065 | Protein kinase B alpha inhibitor | 0.065 0.054 DBMET03064 | DBMET03064 | |
| 0.036 | 0.157 | 0.067 | Thrombin inhibitor | 0.067 0.059 DBMET03063 | DBMET03063 | |
| 0.085 | 0.207 | 0.149 | DNA repair enzyme inhibitor | 0.149 0.032 DBMET03064 | DBMET03064 | |
| 0.026 | 0.152 | 0.093 | MAP kinase 11 inhibitor | 0.093 0.04 DBMET03064 | DBMET03064 | |
| 0.021 | 0.149 | 0.064 | Alpha 1 adrenoreceptor agonist | 0.064 0.032 DBMET03064 | DBMET03064 | |
| 0.032 | 0.162 | 0.082 | DNA gyrase inhibitor | 0.082 0.026 DBMET01559 | DBMET01559 | |
| 0.035 | 0.166 | 0.099 | Rho-associated kinase II inhibitor | 0.099 0.032 DBMET03064 | DBMET03064 | |
| 0.005 | 0.137 | 0.016 | Alpha 2a adrenoreceptor agonist | 0.016 0.014 DBMET03064 | DBMET03064 | |
| 0.091 | 0.228 | 0.235 | Interleukin agonist | 0.216 0.106 DBMET03063 0.235 0.091 DBMET03064 | DBMET03064 | |
| 0.032 | 0.169 | 0.074 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 0.074 0.061 DBMET03064 | DBMET03064 | |
| 0.036 | 0.176 | 0.107 | Protein kinase A inhibitor | 0.107 0.041 DBMET03063 0.082 0.058 DBMET03064 | DBMET03063 | |
| 0.034 | 0.174 | 0.134 | MAP-kinase-activated kinase 2 inhibitor | 0.134 0.015 DBMET03064 | DBMET03064 | |
| 0.022 | 0.162 | 0.082 | Pim-2 kinase inhibitor | 0.082 0.02 DBMET03064 | DBMET03064 | |
| 0.044 | 0.185 | 0.091 | Mediator release inhibitor | 0.091 0.081 DBMET03064 | DBMET03064 | |
| 0.083 | 0.225 | 0.246 | Growth hormone agonist | 0.246 0.044 DBMET03063 | DBMET03063 | |
| 0.032 | 0.174 | 0.138 | CYP2A6 inhibitor | 0.138 0.02 DBMET03064 | DBMET03064 | |
| 0.041 | 0.186 | 0.143 | MAP-kinase-activated kinase inhibitor | 0.143 0.017 DBMET03064 | DBMET03064 | |
| 0.015 | 0.163 | 0.043 | Thymidylate synthase inhibitor | 0.043 0.038 DBMET03064 | DBMET03064 | |
| 0.009 | 0.159 | 0.026 | LFA antagonist | 0.026 0.023 DBMET03064 | DBMET03064 | |
| 0.031 | 0.182 | 0.085 | MAP kinase 10 inhibitor | 0.085 0.046 DBMET03064 | DBMET03064 | |
| 0.21 | 0.361 | 0.379 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.379 0.12 DBMET03064 | DBMET03064 | |
| 0.046 | 0.198 | 0.179 | Glycogen synthase kinase-3 alpha inhibitor | 0.179 0.048 DBMET03064 | DBMET03064 | |
| 0.006 | 0.159 | 0.03 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.03 0.008 DBMET03064 | DBMET03064 | |
| 0.033 | 0.187 | 0.092 | Aryl hydrocarbon receptor antagonist | 0.092 0.017 DBMET03064 | DBMET03064 | |
| 0.095 | 0.249 | 0.173 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.173 0.101 DBMET03064 | DBMET03064 | |
| 0.065 | 0.22 | 0.121 | Interleukin 4 antagonist | 0.121 0.085 DBMET03064 | DBMET03064 | |
| 0.047 | 0.203 | 0.082 | MDM2 inhibitor | 0.082 0.018 DBMET03064 | DBMET03064 | |
| 0.009 | 0.165 | 0.081 | Potassium channel small-conductance Ca-activated activator | 0.081 0.005 DBMET03064 | DBMET03064 | |
| 0.026 | 0.183 | 0.066 | CDK2/cyclin E2 inhibitor | 0.066 0.053 DBMET03064 | DBMET03064 | |
| 0.005 | 0.162 | 0.021 | Complement factor D inhibitor | 0.021 0.007 DBMET03064 | DBMET03064 | |
| 0.056 | 0.213 | 0.157 | Sodium channel (voltage-gated) blocker | 0.157 0.05 DBMET03064 | DBMET03064 | |
| 0.02 | 0.178 | 0.151 | GABA A receptor antagonist | 0.151 0.009 DBMET03064 | DBMET03064 | |
| 0.057 | 0.215 | 0.164 | Sodium channel blocker | 0.164 0.049 DBMET03064 | DBMET03064 | |
| 0.022 | 0.181 | 0.068 | GABA B receptor antagonist | 0.052 0.018 DBMET03063 0.068 0.009 DBMET03064 | DBMET03064 | |
| 0.058 | 0.219 | 0.209 | CDC-like kinase 1 inhibitor | 0.209 0.031 DBMET03064 | DBMET03064 | |
| 0.044 | 0.206 | 0.096 | Aminoacyl-tRNA synthetase inhibitor | 0.096 0.049 DBMET03063 | DBMET03063 | |
| 0.06 | 0.225 | 0.1 | Aldehyde dehydrogenase inhibitor | 0.1 0.098 DBMET03064 | DBMET03064 | |
| 0.012 | 0.177 | 0.041 | Alpha 1d adrenoreceptor agonist | 0.041 0.025 DBMET03064 | DBMET03064 | |
| 0.051 | 0.216 | 0.138 | Epidermal growth factor receptor kinase inhibitor | 0.138 0.057 DBMET03064 | DBMET03064 | |
| 0.019 | 0.187 | 0.087 | Glutamate (mGluR group III) agonist | 0.087 0.012 DBMET03064 | DBMET03064 | |
| 0.007 | 0.175 | 0.033 | Kinesin-like protein 1 inhibitor | 0.033 0.031 DBMET03063 | DBMET03063 | |
| 0.007 | 0.175 | 0.033 | Kinesin antagonist | 0.033 0.031 DBMET03063 | DBMET03063 | |
| 0.018 | 0.186 | 0.05 | Acid-sensing ion channel blocker | 0.05 0.016 DBMET03064 | DBMET03064 | |
| 0.028 | 0.197 | 0.104 | 5 Hydroxytryptamine 3 agonist | 0.104 0.014 DBMET03064 | DBMET03064 | |
| 0.041 | 0.21 | 0.096 | MAP kinase 8 inhibitor | 0.096 0.065 DBMET03064 | DBMET03064 | |
| 0.014 | 0.186 | 0.039 | CDK5/p25 inhibitor | 0.039 0.031 DBMET03064 | DBMET03064 | |
| 0.011 | 0.184 | 0.049 | Glutamate (mGluR5) antagonist | 0.049 0.03 DBMET03064 | DBMET03064 | |
| 0.018 | 0.191 | 0.15 | GABA receptor antagonist | 0.15 0.009 DBMET03064 | DBMET03064 | |
| 0.037 | 0.212 | 0.11 | Urease inhibitor | 0.11 0.056 DBMET03064 | DBMET03064 | |
| 0.037 | 0.212 | 0.086 | Vascular endothelial growth factor 1 antagonist | 0.086 0.077 DBMET03064 | DBMET03064 | |
| 0.044 | 0.22 | 0.171 | 5 Hydroxytryptamine 3A agonist | 0.092 0.086 DBMET03063 0.171 0.025 DBMET03064 | DBMET03064 | |
| 0.109 | 0.286 | 0.225 | Transcription factor NF kappa B inhibitor | 0.225 0.146 DBMET03064 | DBMET03064 | |
| 0.024 | 0.203 | 0.088 | Nav1.8 sodium channel blocker | 0.088 0.035 DBMET03064 | DBMET03064 | |
| 0.022 | 0.202 | 0.051 | Glutamate (mGluR4) antagonist | 0.051 0.02 DBMET03064 | DBMET03064 | |
| 0.035 | 0.216 | 0.087 | Adenosine A3 receptor antagonist | 0.087 0.035 DBMET03064 | DBMET03064 | |
| 0.032 | 0.213 | 0.077 | GABA aminotransferase inhibitor | 0.077 0.051 DBMET03063 0.076 0.051 DBMET03064 | DBMET03063 | |
| 0.077 | 0.261 | 0.154 | Hemostatic | 0.13 0.096 DBMET03063 0.154 0.063 DBMET03064 | DBMET03064 | |
| 0.042 | 0.226 | 0.219 | Cystathionine beta-synthase inhibitor | 0.219 0.02 DBMET03064 | DBMET03064 | |
| 0.032 | 0.216 | 0.132 | MAP kinase kinase kinase inhibitor | 0.132 0.044 DBMET03064 | DBMET03064 | |
| 0.044 | 0.23 | 0.099 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.099 0.055 DBMET03064 | DBMET03064 | |
| 0.165 | 0.351 | 0.36 | MAP kinase 1 inhibitor | 0.36 0.13 DBMET03064 | DBMET03064 | |
| 0.118 | 0.304 | 0.206 | Transcription factor STAT inhibitor | 0.206 0.13 DBMET03063 | DBMET03063 | |
| 0.015 | 0.202 | 0.054 | Nerve growth factor antagonist | 0.054 0.014 DBMET03064 | DBMET03064 | |
| 0.089 | 0.276 | 0.329 | Neurotrophic factor enhancer | 0.329 0.012 DBMET03064 | DBMET03064 | |
| 0.031 | 0.221 | 0.077 | Epidermal growth factor antagonist | 0.077 0.069 DBMET03064 | DBMET03064 | |
| 0.016 | 0.206 | 0.043 | Tryptophan 5 hydroxylase inhibitor | 0.043 0.011 DBMET03064 | DBMET03064 | |
| 0.021 | 0.212 | 0.045 | Cytokine production stimulant | 0.045 0.044 DBMET03064 | DBMET03064 | |
| 0.036 | 0.227 | 0.12 | Hepatocyte growth factor antagonist | 0.12 0.036 DBMET03064 | DBMET03064 | |
| 0.033 | 0.225 | 0.098 | Granulocyte macrophage colony stimulating factor antagonist | 0.098 0.074 DBMET03064 | DBMET03064 | |
| 0.038 | 0.231 | 0.092 | Ephrin antagonist | 0.092 0.071 DBMET03064 | DBMET03064 | |
| 0.043 | 0.237 | 0.135 | GABA receptor agonist | 0.135 0.045 DBMET03064 | DBMET03064 | |
| 0.031 | 0.225 | 0.091 | Check point kinase 2 inhibitor | 0.091 0.074 DBMET03064 | DBMET03064 | |
| 0.007 | 0.202 | 0.038 | 5 Hydroxytryptamine 3B antagonist | 0.038 0.022 DBMET03064 | DBMET03064 | |
| 0.092 | 0.287 | 0.137 | Phospholipase C inhibitor | 0.137 0.136 DBMET03063 | DBMET03063 | |
| 0.019 | 0.215 | 0.072 | CDC7 inhibitor | 0.072 0.042 DBMET03064 | DBMET03064 | |
| 0.016 | 0.212 | 0.089 | NMDA receptor glycine site agonist | 0.089 0.022 DBMET03064 | DBMET03064 | |
| 0.087 | 0.285 | 0.142 | Death-associated protein kinase 1 inhibitor | 0.142 0.052 DBMET03064 | DBMET03064 | |
| 0.033 | 0.231 | 0.119 | Pim-1 kinase inhibitor | 0.119 0.043 DBMET03064 | DBMET03064 | |
| 0.027 | 0.226 | 0.049 | Heme oxygenase inhibitor | 0.049 0.014 DBMET03064 | DBMET03064 | |
| 0.017 | 0.216 | 0.096 | 5 Hydroxytryptamine 3 antagonist | 0.096 0.018 DBMET03064 | DBMET03064 | |
| 0.039 | 0.24 | 0.115 | Lck kinase inhibitor | 0.115 0.089 DBMET03064 | DBMET03064 | |
| 0.072 | 0.275 | 0.118 | Sphingosine 1-phosphate receptor 2 antagonist | 0.118 0.101 DBMET01559 | DBMET01559 | |
| 0.045 | 0.249 | 0.2 | MAP kinase kinase inhibitor | 0.2 0.028 DBMET03064 | DBMET03064 | |
| 0.063 | 0.268 | 0.15 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.15 0.095 DBMET03064 | DBMET03064 | |
| 0.006 | 0.213 | 0.033 | Nicotinic alpha3beta4 receptor agonist | 0.033 0.016 DBMET03064 | DBMET03064 | |
| 0.064 | 0.273 | 0.381 | Dyrk kinase inhibitor | 0.381 0.03 DBMET03064 | DBMET03064 | |
| 0.054 | 0.264 | 0.124 | NADPH oxidase inhibitor | 0.124 0.078 DBMET03064 | DBMET03064 | |
| 0.004 | 0.215 | 0.03 | NMDA receptor glycine site antagonist | 0.03 0.013 DBMET03064 | DBMET03064 | |
| 0.008 | 0.222 | 0.036 | Dihydropteroate synthase inhibitor | 0.036 0.032 DBMET03064 | DBMET03064 | |
| 0.12 | 0.334 | 0.251 | Nitric-oxide synthase stimulant | 0.251 0.032 DBMET03064 | DBMET03064 | |
| 0.032 | 0.25 | 0.103 | Glycogen synthase kinase-3 inhibitor | 0.103 0.077 DBMET03064 | DBMET03064 | |
| 0.009 | 0.227 | 0.07 | Fructose-1,6-bisphosphatase inhibitor | 0.07 0.012 DBMET03064 | DBMET03064 | |
| 0.024 | 0.242 | 0.079 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.079 0.052 DBMET03064 | DBMET03064 | |
| 0.037 | 0.257 | 0.147 | GABA C receptor agonist | 0.111 0.056 DBMET03063 0.147 0.035 DBMET03064 | DBMET03064 | |
| 0.049 | 0.269 | 0.122 | Activin receptor-like kinase 4 inhibitor | 0.122 0.05 DBMET03064 | DBMET03064 | |
| 0.044 | 0.268 | 0.128 | Beta amyloid protein antagonist | 0.128 0.059 DBMET03064 | DBMET03064 | |
| 0.004 | 0.229 | 0.016 | Sodium/hydrogen exchanger inhibitor | 0.016 0.015 DBMET03064 | DBMET03064 | |
| 0.105 | 0.33 | 0.134 | Heat shock protein 70 antagonist | 0.134 0.101 DBMET03064 | DBMET03064 | |
| 0.015 | 0.242 | 0.062 | EphB4 antagonist | 0.062 0.037 DBMET03064 | DBMET03064 | |
| 0.032 | 0.259 | 0.058 | Phosphodiesterase 1C inhibitor | 0.058 0.054 DBMET03064 | DBMET03064 | |
| 0.072 | 0.3 | 0.123 | Adenylate cyclase stimulant | 0.123 0.117 DBMET03064 | DBMET03064 | |
| 0.018 | 0.247 | 0.052 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.052 0.013 DBMET03064 | DBMET03064 | |
| 0.049 | 0.281 | 0.623 | Aryl hydrocarbon receptor agonist | 0.623 0.013 DBMET03064 | DBMET03064 | |
| 0.038 | 0.273 | 0.102 | Protein kinase C gamma inhibitor | 0.102 0.074 DBMET03064 | DBMET03064 | |
| 0.099 | 0.335 | 0.202 | Angiogenesis inhibitor | 0.202 0.167 DBMET03064 | DBMET03064 | |
| 0.073 | 0.31 | 0.21 | Tumour necrosis factor antagonist | 0.21 0.048 DBMET03064 | DBMET03064 | |
| 0.028 | 0.269 | 0.104 | Glycogen synthase kinase-3 beta inhibitor | 0.104 0.074 DBMET03064 | DBMET03064 | |
| 0.026 | 0.269 | 0.107 | Inducible nitric-oxide synthase inhibitor | 0.087 0.052 DBMET03063 0.107 0.031 DBMET03064 | DBMET03064 | |
| 0.047 | 0.29 | 0.114 | Carbonic anhydrase XV inhibitor | 0.114 0.051 DBMET03064 | DBMET03064 | |
| 0.025 | 0.269 | 0.075 | Protein kinase B beta inhibitor | 0.075 0.048 DBMET03064 | DBMET03064 | |
| 0.029 | 0.275 | 0.174 | Protein kinase (CK1) inhibitor | 0.174 0.051 DBMET03064 | DBMET03064 | |
| 0.004 | 0.257 | 0.052 | Kynurenine 3 monooxygenase inhibitor | 0.052 0.006 DBMET03064 | DBMET03064 | |
| 0.016 | 0.27 | 0.059 | 5 Hydroxytryptamine 3A antagonist | 0.059 0.058 DBMET03064 | DBMET03064 | |
| 0.01 | 0.266 | 0.05 | Adenosine A1 receptor antagonist | 0.05 0.049 DBMET03064 | DBMET03064 | |
| 0.073 | 0.329 | 0.18 | Succinate dehydrogenase inhibitor | 0.18 0.067 DBMET03064 | DBMET03064 | |
| 0.031 | 0.288 | 0.075 | GABA A receptor agonist | 0.075 0.074 DBMET03064 | DBMET03064 | |
| 0.03 | 0.291 | 0.144 | Cyclin-dependent kinase 9 inhibitor | 0.144 0.036 DBMET03064 | DBMET03064 | |
| 0.024 | 0.288 | 0.056 | Pregnane X receptor antagonist | 0.056 0.042 DBMET03064 | DBMET03064 | |
| 0.017 | 0.283 | 0.067 | Histidine decarboxylase inhibitor | 0.067 0.054 DBMET03064 | DBMET03064 | |
| 0.032 | 0.3 | 0.054 | Immunoglobulin Fc receptor antagonist | 0.054 0.042 DBMET03064 | DBMET03064 | |
| 0.057 | 0.326 | 0.113 | Sphingosine 1-phosphate receptor 4 antagonist | 0.113 0.087 DBMET03064 | DBMET03064 | |
| 0.029 | 0.299 | 0.069 | I kappa B kinase 1 inhibitor | 0.069 0.05 DBMET03064 | DBMET03064 | |
| 0.009 | 0.286 | 0.034 | Glutamate (mGluR3) antagonist | 0.034 0.029 DBMET03064 | DBMET03064 | |
| 0.044 | 0.324 | 0.098 | D-Ala-D-Ala ligase inhibitor | 0.098 0.032 DBMET03064 | DBMET03064 | |
| 0.039 | 0.319 | 0.124 | Phosphodiesterase 7B inhibitor | 0.124 0.034 DBMET03064 | DBMET03064 | |
| 0.029 | 0.31 | 0.093 | Creatine kinase inhibitor | 0.093 0.067 DBMET03064 | DBMET03064 | |
| 0.042 | 0.324 | 0.36 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.36 0.033 DBMET03064 | DBMET03064 | |
| 0.012 | 0.293 | 0.047 | Adenosine deaminase inhibitor | 0.047 0.034 DBMET03064 | DBMET03064 | |
| 0.017 | 0.298 | 0.08 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 0.08 0.072 DBMET03064 | DBMET03064 | |
| 0.055 | 0.34 | 0.203 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.203 0.098 DBMET03064 | DBMET03064 | |
| 0.042 | 0.328 | 0.109 | Nav1.5 sodium channel blocker | 0.109 0.07 DBMET03064 | DBMET03064 | |
| 0.034 | 0.323 | 0.098 | Beta glucuronidase inhibitor | 0.098 0.072 DBMET03064 | DBMET03064 | |
| 0.029 | 0.318 | 0.094 | Potassium channel (Voltage-sensitive) activator | 0.094 0.062 DBMET03064 | DBMET03064 | |
| 0.015 | 0.308 | 0.063 | Aconitate hydratase inhibitor | 0.063 0.024 DBMET03064 | DBMET03064 | |
| 0.031 | 0.327 | 0.067 | Glutamate (mGluR6) antagonist | 0.067 0.046 DBMET03064 | DBMET03064 | |
| 0.096 | 0.396 | 0.142 | Ca2+-transporting ATPase inhibitor | 0.142 0.065 DBMET03064 | DBMET03064 | |
| 0.085 | 0.388 | 0.3 | 15-Lipoxygenase inhibitor | 0.3 0.132 DBMET03064 | DBMET03064 | |
| 0.083 | 0.388 | 0.193 | Cholesterol antagonist | 0.193 0.171 DBMET03064 | DBMET03064 | |
| 0.011 | 0.324 | 0.025 | Complement factor 1s inhibitor | 0.025 0.018 DBMET03064 | DBMET03064 | |
| 0.028 | 0.343 | 0.115 | Ferrochelatase inhibitor | 0.115 0.057 DBMET03064 | DBMET03064 | |
| 0.032 | 0.348 | 0.085 | DNA directed RNA polymerase inhibitor | 0.085 0.077 DBMET03064 | DBMET03064 | |
| 0.013 | 0.332 | 0.063 | Nav1.7 sodium channel blocker | 0.063 0.053 DBMET03064 | DBMET03064 | |
| 0.011 | 0.333 | 0.067 | NMDA 2B receptor antagonist | 0.067 0.026 DBMET03064 | DBMET03064 | |
| 0.128 | 0.452 | 0.321 | MAP kinase kinase 6 inhibitor | 0.321 0.116 DBMET03064 | DBMET03064 | |
| 0.091 | 0.418 | 0.236 | Antibacterial | 0.217 0.21 DBMET03063 0.236 0.19 DBMET03064 | DBMET03064 | |
| 0.04 | 0.369 | 0.116 | Cell wall synthesis inhibitor | 0.116 0.106 DBMET03064 | DBMET03064 | |
| 0.03 | 0.37 | 0.079 | GABA B receptor agonist | 0.079 0.043 DBMET03064 | DBMET03064 | |
| 0.027 | 0.367 | 0.07 | Glycine receptor agonist | 0.07 0.055 DBMET03064 | DBMET03064 | |
| 0.017 | 0.358 | 0.045 | Glutamate (mGluR group III) antagonist | 0.045 0.027 DBMET03064 | DBMET03064 | |
| 0.009 | 0.357 | 0.054 | Alcohol oxidase inhibitor | 0.054 0.041 DBMET03064 | DBMET03064 | |
| 0.031 | 0.38 | 0.089 | Transcription factor RelA inhibitor | 0.089 0.011 DBMET03064 | DBMET03064 | |
| 0.032 | 0.381 | 0.142 | Pyruvate kinase inhibitor | 0.142 0.123 DBMET03064 | DBMET03064 | |
| 0.052 | 0.406 | 0.139 | Non-steroidal antiinflammatory agent | 0.139 0.132 DBMET03064 | DBMET03064 | |
| 0.02 | 0.38 | 0.099 | I kappa B kinase inhibitor | 0.099 0.039 DBMET03064 | DBMET03064 | |
| 0.121 | 0.486 | 0.271 | MAP kinase kinase 3 inhibitor | 0.271 0.017 DBMET03064 | DBMET03064 | |
| 0.004 | 0.375 | 0.062 | Urate transporter 1 inhibitor | 0.062 0.013 DBMET03064 | DBMET03064 | |
| 0.058 | 0.44 | 0.197 | DNA synthesis inhibitor | 0.197 0.128 DBMET03064 | DBMET03064 | |
| 0.03 | 0.416 | 0.156 | EphB2 antagonist | 0.156 0.123 DBMET03064 | DBMET03064 | |
| 0.049 | 0.456 | 0.245 | 12-Lipoxygenase inhibitor | 0.245 0.112 DBMET03064 | DBMET03064 | |
| 0.048 | 0.455 | 0.182 | 3C-like protease (Human coronavirus) inhibitor | 0.182 0.064 DBMET03064 | DBMET03064 | |
| 0.014 | 0.427 | 0.064 | I kappa B kinase 2 inhibitor | 0.064 0.04 DBMET03064 | DBMET03064 | |
| 0.031 | 0.445 | 0.195 | Mannose-6-phosphate isomerase inhibitor | 0.195 0.033 DBMET03064 | DBMET03064 | |
| 0.022 | 0.449 | 0.094 | Exportin-1 inhibitor | 0.094 0.012 DBMET03064 | DBMET03064 | |
| 0.029 | 0.46 | 0.085 | mTOR complex 2 inhibitor | 0.085 0.056 DBMET03064 | DBMET03064 | |
| 0.039 | 0.473 | 0.174 | Streptokinase A inhibitor | 0.174 0.151 DBMET03064 | DBMET03064 | |
| 0.029 | 0.47 | 0.111 | DOPA decarboxylase inhibitor | 0.111 0.057 DBMET03064 | DBMET03064 | |
| 0.007 | 0.45 | 0.117 | Protein kinase (CK1) delta inhibitor | 0.117 0.076 DBMET03064 | DBMET03064 | |
| 0.036 | 0.485 | 0.104 | Toll-Like receptor 3 antagonist | 0.104 0.045 DBMET03064 | DBMET03064 | |
| 0.047 | 0.498 | 0.161 | CF transmembrane conductance regulator agonist | 0.161 0.058 DBMET03064 | DBMET03064 | |
| 0.026 | 0.496 | 0.146 | Arachidonic acid antagonist | 0.146 0.093 DBMET03064 | DBMET03064 | |
| 0.022 | 0.512 | 0.132 | HIV-1 integrase (Overall Integration) inhibitor | 0.132 0.033 DBMET03064 | DBMET03064 | |
| 0.035 | 0.551 | 0.173 | Hexokinase inhibitor | 0.173 0.055 DBMET03064 | DBMET03064 | |
| 0.033 | 0.616 | 0.095 | Interleukin 12 antagonist | 0.095 0.062 DBMET03064 | DBMET03064 | |
| 0.025 | 0.672 | 0.198 | Histone acetyltransferase inhibitor | 0.198 0.072 DBMET03064 | DBMET03064 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |